Q92BG2 AF NFT

Valine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeieszw6ubghctcmv4ntux6st6zm5vco472hyoyoxbrmwqedc3bwk4u/metadata.json
IPFS of structure file: 
bafybeihde7zkfignywuowpqove5hdpd2mzy6nxhew4dt6nctt3fv4t44uy/AF-Q92BG2-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x94351391A793C927223B6941B5741878B0F79eEF
First NFT owner address (bech32): 
genesis1js638yd8j0yjwg3md9qm2aqc0zc008h0xckq57
Current NFT ID #454959 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
454959
Accession (UniProt):
Q92BG2
Name::
Valine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
LISTERIA INNOCUA SEROVAR 6A (STRAIN ATCC BAA-680 / CLIP 11262)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q92BG2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q92BG2|SYV_LISIN Valine--tRNA ligase OS=Listeria innocua serovar 6a (strain ATCC BAA-680 / CLIP 11262) OX=272626 GN=valS PE=3 SV=1 MTEQNEINMPTKYEPSNVEAGKYKWWLEKEFFKAEGNSDKKPYSIVIPPPNVTGKLHLGHAWDTTLQDIITRMKRMQGFDTLYLPGMDHAGIATQAKVEAKLKEENISRYDLGREKFVDKTWEWKEEYADFIREQWEKLGLGLDYSRERFTLDAGLSDAVKKVFVTLYNKGLIYRGQYIINWDPEAKTALSDIEVIHKDIEGSFYHLKYPLTDGSGYLEVATTRPETIPGDTAVAVHPKDERYQHLIGKTIMLPILNREIPIVADEYVEREFGSGAVKITPAHDPNDFEVGNRHDLPRIIVMHEDGTMNDNAGKYDGLDRFVARKAIIQDFKDLGLFIKQEPHLHSVGHSERTGAVVEPYLSLQWFVKMEPLAAEALALQKTEDKVNFVPARFEKTYETWMDNIHDWCISRQLWWGHRIPAWYHKETGEIYVGENEPENLDQWEQDEDVLDTWFSSALWPFSTMGWPDTENPDYKHFFPTNTLVTGYDIIFFWVSRMIFQSVEFTGERPFKDTLIHGLVRDSEGRKMSKSLGNGVDPIEVIDKYGADSLRYTLATGSSPGQDLKFSFEKVESTWNFINKIWNASRFVLMNLDGMKYDEIDLSNVTEVSDKWILTRLNETIQAVTSLGEKYEFGEVGRTLYNFIWDDFCDWYIEIAKIPLYGEDEVAKQTTRSVLAYTLNTTMRLLHPFMPFVTEEIWQNLPHEGESITISNWPEVNEQQMDSKASTAMRTLVEVIRAVRNIRAEVNTPLSKSIVLEIKPKDETYKEILEQNISYIERFCNPEKVTIAFDIEPSKTAMTAVVSGAEIFIPLEALIDLDLEIARLEKELEKWNKEVARVQGKLNNERFISKAPENVVAEERLKEKDYLEKKASVLERIETLKEV